JMD Am. J. Pathology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bejjani, B. A.
Right arrow Articles by Shaffer, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bejjani, B. A.
Right arrow Articles by Shaffer, L. G.
JMD 2006, Vol. 8, No. 5
Copyright © 2006 American Society for Investigative Pathology & Association for Molecular Pathology

Review Article

Application of Array-Based Comparative Genomic Hybridization to Clinical Diagnostics

Bassem A. Bejjani and Lisa G. Shaffer

From Signature Genomic Laboratories, LLC, Spokane, Washington

Abstract

Microarray-based comparative genomic hybridization (array CGH) is a revolutionary platform that was recently adopted in the clinical laboratory. This technology was first developed as a research tool for the investigation of genomic alterations in cancer. It allows for a high-resolution evaluation of DNA copy number alterations associated with chromosome abnormalities. Array CGH is based on the use of differentially labeled test and reference genomic DNA samples that are simultaneously hybridized to DNA targets arrayed on a glass slide or other solid platform. In this review, we examine the technology and its transformation from a research tool into a maturing diagnostic instrument. We also evaluate the various approaches that have shaped the current platforms that are used for clinical applications. Finally, we discuss the advantages and shortcomings of "whole-genome" arrays and compare their diagnostic use to "targeted" arrays. Depending on their design, microarrays provide distinct advantages over conventional cytogenetic analysis because they have the potential to detect the majority of microscopic and submicroscopic chromosomal abnormalities. This new platform is poised to revolutionize modern cytogenetic diagnostics and to provide clinicians with a powerful tool to use in their increasingly sophisticated diagnostic capabilities.




This article has been cited by other articles:


Home page
 Clin. Chem.Home page
Y. Shen, D. T. Miller, S. W. Cheung, V. Lip, X. Sheng, K. Tomaszewicz, H. Shao, H. Fang, H. S. Tang, M. Irons, et al.
Development of a Focused Oligonucleotide-Array Comparative Genomic Hybridization Chip for Clinical Diagnosis of Genomic Imbalance
Clin. Chem., December 1, 2007; 53(12): 2051 - 2059.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
J. A. Veltman and B. B.A. de Vries
Whole-Genome Array Comparative Genome Hybridization: The Preferred Diagnostic Choice in Postnatal Clinical Cytogenetics
J. Mol. Diagn., April 1, 2007; 9(2): 277 - 277.
[Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
J. A. Wilson and D. Barton
Targeted versus Whole-Genome Array Comparative Genome Hybridization: The Atlantic Divide
J. Mol. Diagn., April 1, 2007; 9(2): 278 - 278.
[Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
J. A. Veltman and B. B.A. de Vries
Diagnostic Genome Profiling: Unbiased Whole Genome or Targeted Analysis?
J. Mol. Diagn., November 1, 2006; 8(5): 534 - 537.
[Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
B. A. Bejjani and L. G. Shaffer
Targeted Array CGH
J. Mol. Diagn., November 1, 2006; 8(5): 537 - 539.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Society for Investigative Pathology and the Association for Molecular Pathology.